Works by Braiteh, Fadi

Results: 32

Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors.

Published in:

Oncology, 2016, v. 91, n. 5, p. 251, doi. 10.1159/000448621

By:

Calvo, Emiliano;
Braiteh, Fadi;
Von Hoff, Daniel;
McWilliams, Robert;
Becerra, Carlos;
Galsky, Matthew D.;
Jameson, Gayle;
Lin, Ji;
McKane, Scott;
Wickremsinhe, Enaksha R.;
Hynes, Scott M.;
Bence Lin, aimee;
Hurt, Karla;
Richards, Donald

Publication type:

Article

Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.

Published in:

Oncologist, 2017, v. 22, n. 7, p. 774, doi. 10.1634/theoncologist.2016-0376

By:

Lai, Andrea Z.;
Schrock, Alexa B.;
Erlich, Rachel L.;
Ross, Jeffrey S.;
Miller, Vincent A.;
Yakirevich, Evgeny;
Ali, Siraj M.;
Braiteh, Fadi

Publication type:

Article

Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.

Published in:

Oncologist, 2017, v. 22, n. 4, p. 375, doi. 10.1634/theoncologist.2016-0133

By:

García‐Carbonero, Rocío;
van Cutsem, Eric;
Rivera, Fernando;
Jassem, Jacek;
Gore, Ira;
Tebbutt, Niall;
Braiteh, Fadi;
Argiles, Guillem;
Wainberg, Zev A.;
Funke, Roel;
Anderson, Maria;
McCall, Bruce;
Stroh, Mark;
Wakshull, Eric;
Hegde, Priti;
Ye, Weilan;
Chen, Daniel;
Chang, Ilsung;
Rhee, Ina;
Hurwitz, Herbert

Publication type:

Article

Predictors of Access to Palliative Care Services among Patients Who Died at a Comprehensive Cancer Center.

Published in:

Journal of Palliative Medicine, 2007, v. 10, n. 5, p. 1146, doi. 10.1089/jpm.2006.0259

By:

Fadul, Nada;
Elsayem, Ahmed;
Palmer, J. Lynn;
Tao Zhang;
Braiteh, Fadi;
Bruera, Eduardo

Publication type:

Article

Characteristics, Findings, and Outcomes of Palliative Care Inpatient Consultations at a Comprehensive Cancer Center.

Published in:

Journal of Palliative Medicine, 2007, v. 10, n. 4, p. 948, doi. 10.1089/jpm.2006.0257

By:

Braiteh, Fadi;
El Osta, Badi;
Palmer, J. Lynn;
Reddy, Suresh K.;
Bruera, Eduardo

Publication type:

Article

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.

Published in:

2019

By:

Mazzaferro, Vincenzo;
El-Rayes, Bassel F.;
Droz dit Busset, Michele;
Cotsoglou, Christian;
Harris, William P.;
Damjanov, Nevena;
Masi, Gianluca;
Rimassa, Lorenza;
Personeni, Nicola;
Braiteh, Fadi;
Zagonel, Vittorina;
Papadopoulos, Kyriakos P.;
Hall, Terence;
Wang, Yunxia;
Schwartz, Brian;
Kazakin, Julia;
Bhoori, Sherrie;
de Braud, Filippo;
Shaib, Walid L.

Publication type:

journal article

Transient Pneumobilia Following Upper Gastrointestinal Endoscopy.

Published in:

2005

By:

Braiteh, Fadi;
Ramsey, William

Publication type:

Editorial

Pneumobilia fugax.

Published in:

2003

By:

Braiteh, Fadi;
Hojjati, Mehrnaz;
Ramsey, William

Publication type:

Abstract

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study.

Published in:

American Journal of Hematology, 2018, v. 93, n. 5, p. 607, doi. 10.1002/ajh.25043

By:

Gambacorti‐Passerini, Carlo;
Orlov, Sergey;
Zhang, Li;
Braiteh, Fadi;
Huang, Huiqiang;
Esaki, Taito;
Horibe, Keizo;
Ahn, Jin‐Seok;
Beck, Joseph T.;
Edenfield, William Jeffrey;
Shi, Yuankai;
Taylor, Matthew;
Tamura, Kenji;
Van Tine, Brian A.;
Wu, Shang‐Ju;
Paolini, Jolanda;
Selaru, Paulina;
Kim, Tae Min

Publication type:

Article

Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies.

Published in:

Oncologist, 2015, v. 20, n. 5, p. 499, doi. 10.1634/theoncologist.2014-0378

By:

Ali, Siraj M.;
Sanford, Eric M.;
Klempner, Samuel J.;
Rubinson, Douglas A.;
Wang, Kai;
Palma, Norma A.;
Chmielecki, Juliann;
Yelensky, Roman;
Palmer, Gary A.;
Morosini, Deborah;
Lipson, Doron;
Catenacci, Daniel V.;
Braiteh, Fadi;
Erlich, Rachel;
Stephens, Philip J.;
Ross, Jeffrey S.;
Ou, Sai‐Hong Ignatius;
Miller, Vincent A.

Publication type:

Article

Refractory Hodgkin lymphoma responds to pentostatin (2′-deoxycoformycin).

Published in:

2006

By:

Braiteh, Fadi;
Ng, Chaan;
Kurzrock, Razelle

Publication type:

Letter

Spontaneous haemopericardium with subacute cardiac tamponade in a patient with lung cancer receiving coumadin.

Published in:

QJM: An International Journal of Medicine, 2009, v. 102, n. 8, p. 575, doi. 10.1093/qjmed/hcp009

By:

Braiteh, Fadi;
Plana, Juan Carlos

Publication type:

Article

Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.

Published in:

2016

By:

Wang, Ding;
Braiteh, Fadi;
Lee, James;
Denlinger, Crystal;
Shepard, Dale;
Chaudhary, Archana;
Lin, Yong;
Gao, Ling;
Asakiewicz, Christopher;
Nasroulah, Federico;
LoRusso, Patricia;
Lee, James J;
Denlinger, Crystal S;
Shepard, Dale R

Publication type:

journal article

Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 773, doi. 10.1007/s11523-021-00833-2

By:

Hu-Lieskovan, Siwen;
Braiteh, Fadi;
Grilley-Olson, Juneko E.;
Wang, Xiao;
Forgie, Alison;
Bonato, Vinicius;
Jacobs, Ira A.;
Chou, Jeffrey;
Johnson, Melissa L.

Publication type:

Article

Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors.

Published in:

Cancer (0008543X), 2023, v. 129, n. 12, p. 1919, doi. 10.1002/cncr.34733

By:

Pant, Shubham;
Hamilton, Erika;
Ulahannan, Susanna V.;
Strauss, James F.;
Braiteh, Fadi S.;
Huang, Mo;
Liaw, Danny Chih Hsun

Publication type:

Article

An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2015, v. 33, n. 1, p. 148, doi. 10.1007/s10637-014-0160-z

By:

Jotte, Robert;
Von Hoff, Daniel;
Braiteh, Fadi;
Becerra, Carlos;
Richards, Donald;
Smith, David;
Garbo, Lawrence;
Stephenson, Joe;
Conkling, Paul;
Robert-Vizcarrondo, Francisco;
Chen, Jian;
Turner, P.;
Chow, Kay;
Tai, D.;
Ilaria, Robert

Publication type:

Article

Letter to the editor.

Published in:

Clinical Anatomy, 2006, v. 19, n. 7, p. 682, doi. 10.1002/ca.20356

By:

Fadi Braiteh;
Joann T. Lim;
Razelle Kurzrock

Publication type:

Article

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.

Published in:

2017

By:

Wakelee, Heather;
Zvirbule, Zanete;
De Braud, Filippo;
Kingsley, C. Daniel;
Mekhail, Tarek;
Lowe, Thomas;
Schiitte, Wolfgang;
Lena, Herve;
Lawler, William;
Braiteh, Fadi;
Cosgriff, Thomas;
Kaen, Diego;
Boyer, Michelle;
Jessie Hsu;
Phan, See;
Novello, Silvia;
Schütte, Wolfgang;
Lena, Hervé;
Hsu, Jessie

Publication type:

journal article

Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung Cancer.

Published in:

2017

By:

Hirsch, Fred R.;
Govindan, Ramaswamy;
Zvirbule, Zanete;
Braiteh, Fadi;
Rittmeyer, Achim;
Belda-Iniesta, Cristobal;
Isla, Dolores;
Cosgriff, Thomas;
Boyer, Michelle;
Ueda, Masamichi;
Phan, See;
Gandara, David R.;
Belda-Iniesta, Cristóbal

Publication type:

journal article

First‐in‐human, phase I study of PF‐06647263, an anti‐EFNA4 calicheamicin antibody–drug conjugate, in patients with advanced solid tumors.

Published in:

International Journal of Cancer, 2019, v. 145, n. 7, p. 1798, doi. 10.1002/ijc.32154

By:

Garrido‐Laguna, Ignacio;
Krop, Ian;
Burris, Howard A.;
Hamilton, Erika;
Braiteh, Fadi;
Weise, Amy M.;
Abu‐Khalaf, Maysa;
Werner, Theresa L.;
Pirie‐Shepherd, Steven;
Zopf, Christopher J.;
Lakshminarayanan, Mani;
Holland, Jaymes S.;
Baffa, Raffaele;
Hong, David S.

Publication type:

Article

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis.

Published in:

Cancer Management & Research, 2018, v. 10, p. 249, doi. 10.2147/CMAR.S150960

By:

Mahtani, Reshma L;
Parisi, Monika;
Glück, Stefan;
Ni, Quanhong;
Park, Siyeon;
Pelletier, Corey;
Faria, Claudio;
Braiteh, Fadi

Publication type:

Article

Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting.

Published in:

Cancer Management & Research, 2017, v. 9, p. 141, doi. 10.2147/CMAR.S126073

By:

Braiteh, Fadi;
Patel, Manish B.;
Parisi, Monika;
Quanhong Ni;
Siyeon Park;
Faria, Claudio

Publication type:

Article

Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management.

Published in:

Cancer Management & Research, 2014, v. 6, p. 93, doi. 10.2147/CMAR.S52217

By:

Khan, Gazala;
Moss, Rebecca A.;
Braiteh, Fadi;
Saltzman, Marc

Publication type:

Article

Pneumopericardium.

Published in:

Canadian Medical Association Journal (CMAJ), 2008, v. 179, n. 10, p. 1087, doi. 10.1503/cmaj.080707

By:

Braiteh, Fadi;
Malik, Imrana

Publication type:

Article

A suspicion of chikungunya leading to a diagnosis of angioimmunoblastic T-cell lymphoma.

Published in:

Acta Oncologica, 2009, v. 48, n. 4, p. 624, doi. 10.1080/02841860802637773

By:

Braiteh, Fadi;
Parikh, Ankur;
McLaughlin, Peter

Publication type:

Article

Unmet Needs in the Management of Pancreatic Adenocarcinoma.

Published in:

Clinical Advances in Hematology & Oncology, 2017, v. 15, p. 3

By:

Braiteh, Fadi

Publication type:

Article

Recent Advances in the Treatment of Pancreatic Adenocarcinoma.

Published in:

Clinical Advances in Hematology & Oncology, 2017, v. 15, p. 1

By:

Braiteh, Fadi;
Ramanathan, Ramesh K.;
Bekaii-Saab, Tanios

Publication type:

Article

Cases in the Management of GEP-NETs: Combination Regimens.

Published in:

Clinical Advances in Hematology & Oncology, 2016, v. 14, p. 11

By:

Braiteh, Fadi

Publication type:

Article

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.

Published in:

Nature, 2014, v. 515, n. 7528, p. 558, doi. 10.1038/nature13904

By:

Powles, Thomas;
Eder, Joseph Paul;
Petrylak, Daniel P.;
Fine, Gregg D.;
Teng, Siew-leng;
Shen, Xiaodong;
Boyd, Zachary;
Hegde, Priti S.;
Chen, Daniel S.;
Braiteh, Fadi S.;
Loriot, Yohann;
Cruz, Cristina;
Bellmunt, Joaquim;
Burris, Howard A.;
Vogelzang, Nicholas J.

Publication type:

Article

Nivolumab and Ipilimumab Combination Therapy for Second-Line Treatment of Hepatocellular Carcinoma.

Published in:

Gastroenterology & Hepatology, 2021, p. 82

By:

Braiteh, Fadi

Publication type:

Article

Association of Age and Survival in Patients With Gastroesophageal Cancer Undergoing Surgery With or Without Preoperative Therapy.

Published in:

Cancer (0008543X), 2009, v. 115, n. 19, p. 4450, doi. 10.1002/cncr.24488

By:

Braiteh, Fadi;
Correa, Arlene M.;
Hofstetter, Wayne L.;
Rice, David C.;
Vaporciyan, Ara A.;
Walsh, Garrett L.;
Roth, Jack A.;
Mehran, Reza J.;
Swisher, Stephen G.;
Ajani, Jaffer A.

Publication type:

Article

Liposome‐encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis.

Published in:

Cancer (0008543X), 2005, v. 104, n. 6, p. 1322, doi. 10.1002/cncr.21300

By:

Lan Li;
Fadi S. Braiteh;
Razelle Kurzrock

Publication type:

Article